AI could predict bladder cancer treatment target without extra biopsy
NCT ID NCT07454941
Summary
This study is testing a new artificial intelligence (AI) tool designed to predict a specific cancer marker called HER2 in bladder cancer. The AI analyzes a patient's existing MRI scans and digital pathology images to see if it can accurately determine HER2 status, which helps guide targeted therapy decisions. If successful, this could help doctors plan treatment without needing additional invasive procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences Beijing
Beijing, Chaoyang District, 100021, China
Conditions
Explore the condition pages connected to this study.